PRME completes 5th wave and is at the beginning of an uptrendPrime Medicine NASDAQ:PRME
PRME completes 5th wave and is at the beginning of an uptrend.
Next report date
Report period
Q1 2024
EPS estimate
−0.45USD
Revenue estimate
1.92 MUSD
−2.14USD
−198.13 MUSD
49.77 M
About Prime Medicine, Inc.
Sector
Industry
CEO
Keith M. Gottesdiener
Website
Headquarters
Cambridge
Employees (FY)
234
Founded
2019
FIGI
BBG011RT3R55
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PRME is 4.43 USD — it has increased by 2.91% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Prime Medicine, Inc. stocks are traded under the ticker PRME.
Prime Medicine, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
PRME stock is 11.78% volatile and has beta coefficient of 3.09. Check out the list of the most volatile stocks — is Prime Medicine, Inc. there?
PRME earnings for the last quarter are −0.55 USD per share, whereas the estimation was −0.43 USD resulting in a −26.68% surprise. The estimated earnings for the next quarter are −0.56 USD per share. See more details about Prime Medicine, Inc. earnings.
Yes, you can track Prime Medicine, Inc. financials in yearly and quarterly reports right on TradingView.
PRME stock has fallen by 3.59% compared to the previous week, the month change is a 34.73% fall, over the last year Prime Medicine, Inc. has showed a 66.58% decrease.
PRME net income for the last quarter is −65.64 M USD, while the quarter before that showed −50.71 M USD of net income which accounts for −29.45% change. Track more Prime Medicine, Inc. financial stats to get the full picture.
Today Prime Medicine, Inc. has the market capitalization of 530.73 M, it has decreased by 9.30% over the last week.
No, PRME doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PRME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Prime Medicine, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 234.00 employees. See our rating of the largest employees — is Prime Medicine, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Prime Medicine, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Prime Medicine, Inc. stock shows the strong sell signal. See more of Prime Medicine, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Prime Medicine, Inc. future price: according to them, PRME price has a max estimate of 20.00 USD and a min estimate of 9.00 USD. Read a more detailed Prime Medicine, Inc. forecast: see what analysts think of Prime Medicine, Inc. and suggest that you do with its stocks.